Free Trial

Illumina (ILMN) Competitors

$108.66
-0.56 (-0.51%)
(As of 06/14/2024 ET)

ILMN vs. AVTR, PKI, A, MTD, WAT, TECH, CRL, BRKR, BIO, and PACB

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Avantor (AVTR), Revvity (PKI), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Bio-Rad Laboratories (BIO), and Pacific Biosciences of California (PACB).

Illumina vs.

Illumina (NASDAQ:ILMN) and Avantor (NYSE:AVTR) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, community ranking, earnings, dividends and profitability.

Avantor has a net margin of 3.79% compared to Illumina's net margin of -28.71%. Avantor's return on equity of 13.01% beat Illumina's return on equity.

Company Net Margins Return on Equity Return on Assets
Illumina-28.71% 2.31% 1.31%
Avantor 3.79%13.01%5.22%

Illumina currently has a consensus price target of $158.14, suggesting a potential upside of 45.54%. Avantor has a consensus price target of $26.71, suggesting a potential upside of 23.22%. Given Illumina's higher probable upside, equities research analysts plainly believe Illumina is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Illumina
2 Sell rating(s)
11 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.29
Avantor
0 Sell rating(s)
4 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.75

Illumina has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Avantor has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

89.4% of Illumina shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 0.2% of Illumina shares are held by insiders. Comparatively, 1.5% of Avantor shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Illumina received 913 more outperform votes than Avantor when rated by MarketBeat users. Likewise, 65.67% of users gave Illumina an outperform vote while only 63.64% of users gave Avantor an outperform vote.

CompanyUnderperformOutperform
IlluminaOutperform Votes
1081
65.67%
Underperform Votes
565
34.33%
AvantorOutperform Votes
168
63.64%
Underperform Votes
96
36.36%

In the previous week, Illumina had 13 more articles in the media than Avantor. MarketBeat recorded 22 mentions for Illumina and 9 mentions for Avantor. Avantor's average media sentiment score of 1.32 beat Illumina's score of 0.60 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Illumina
8 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avantor has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Illumina$4.50B3.84-$1.16B-$8.15-13.33
Avantor$6.97B2.11$321.10M$0.3955.59

Summary

Avantor beats Illumina on 13 of the 18 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$17.31B$4.91B$5.15B$8.40B
Dividend YieldN/A0.42%2.77%4.04%
P/E Ratio-13.3329.92152.0518.06
Price / Sales3.845.942,205.7679.12
Price / Cash30.2837.9234.4931.32
Price / Book3.003.314.854.22
Net Income-$1.16B-$11.37M$110.43M$216.24M
7 Day Performance-4.43%-1.43%-0.41%-0.47%
1 Month Performance-5.52%-10.52%-2.08%-2.38%
1 Year Performance-48.24%-32.82%0.05%2.11%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
4.561 of 5 stars
$22.14
-0.9%
$26.71
+20.7%
+10.9%$15.04B$6.87B56.7614,500Short Interest ↓
Positive News
High Trading Volume
PKI
Revvity
4.1516 of 5 stars
N/A$54.00
+∞
N/A$14.57B$3.31B15.0116,700Analyst Forecast
A
Agilent Technologies
3.9123 of 5 stars
$133.16
+0.8%
$136.50
+2.5%
+8.8%$38.85B$6.83B31.4818,100Insider Selling
MTD
Mettler-Toledo International
4.3448 of 5 stars
$1,459.51
+1.3%
$1,256.25
-13.9%
+10.7%$31.18B$3.79B40.9317,300Positive News
WAT
Waters
4.0669 of 5 stars
$300.96
+0.2%
$307.20
+2.1%
+12.6%$17.85B$2.96B29.537,900Positive News
TECH
Bio-Techne
4.2765 of 5 stars
$77.45
+0.7%
$81.00
+4.6%
+1.3%$12.21B$1.14B61.473,050Positive News
CRL
Charles River Laboratories International
4.562 of 5 stars
$213.84
+1.6%
$256.38
+19.9%
+1.0%$11.01B$4.13B25.1621,800Analyst Downgrade
Short Interest ↑
BRKR
Bruker
4.9378 of 5 stars
$66.21
+2.6%
$85.00
+28.4%
-13.8%$9.62B$2.96B24.089,707Positive News
BIO
Bio-Rad Laboratories
4.5752 of 5 stars
$283.29
+0.8%
$436.67
+54.1%
-23.9%$8.08B$2.67B-27.348,030Insider Selling
Short Interest ↑
Analyst Revision
News Coverage
PACB
Pacific Biosciences of California
2.854 of 5 stars
$1.98
+8.8%
$6.38
+222.0%
-86.7%$539.27M$200.52M-1.74796Positive News
Gap Up

Related Companies and Tools

This page (NASDAQ:ILMN) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners